Cargando…

Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo

PURPOSE: Human mesenchymal stem cells (hMSCs) have been applied in a variety of therapies recently. However, the role of MSCs in tumor progression remains largely elusive. Some studies demonstrated that MSCs can promote tumor growth, while others had opposite results. Therefore, the lack of evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Ming-Yao, Li, Lin, Wang, Wen-Ju, Liu, Fei-Fei, Song, Jian, Yang, Song-Lin, Tan, Jing, Gao, Hui, Zhao, Yi-Yi, Tang, Wei-Wei, Han, Rui, Zhu, Kai, Liao, Li-Wei, Hou, Zong-Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482126/
https://www.ncbi.nlm.nih.gov/pubmed/30805774
http://dx.doi.org/10.1007/s00432-019-02859-6
_version_ 1783413826688909312
author Meng, Ming-Yao
Li, Lin
Wang, Wen-Ju
Liu, Fei-Fei
Song, Jian
Yang, Song-Lin
Tan, Jing
Gao, Hui
Zhao, Yi-Yi
Tang, Wei-Wei
Han, Rui
Zhu, Kai
Liao, Li-Wei
Hou, Zong-Liu
author_facet Meng, Ming-Yao
Li, Lin
Wang, Wen-Ju
Liu, Fei-Fei
Song, Jian
Yang, Song-Lin
Tan, Jing
Gao, Hui
Zhao, Yi-Yi
Tang, Wei-Wei
Han, Rui
Zhu, Kai
Liao, Li-Wei
Hou, Zong-Liu
author_sort Meng, Ming-Yao
collection PubMed
description PURPOSE: Human mesenchymal stem cells (hMSCs) have been applied in a variety of therapies recently. However, the role of MSCs in tumor progression remains largely elusive. Some studies demonstrated that MSCs can promote tumor growth, while others had opposite results. Therefore, the lack of evidence about the effect of MSCs on tumor cells impedes its further use. METHODS: In the current study, hMSCs from amniotic membrane (hAMSCs) and umbilical cord (hUCMSCs) were used to evaluate the effects of MSCs on tumor development in vitro and in vivo. Two different animal models based on subcutaneous xenograft bearing nude mice and a murine experimental metastatic model were established for in vivo study. Moreover, cytokines regulated by MSCs co-cultured with cancer cells SPC-A-1 were also analyzed by cytokine array. RESULTS: Our results indicated that hUCMSCs not only did not promote proliferation in cancer cells, but also inhibited migration. In addition, they inhibited tube formation in human umbilical vein endothelial cells (HUVECs). Although hAMSCs also showed inhibitory effects on cancer cell motility, the proliferation of cancer cells was indeed enhanced. The in vivo data revealed that hUCMSCs did not promote tumor progression in lung adenocarcinoma and gastric carcinoma xenografts. Nevertheless, hAMSCs could do. The results from murine experimental metastatic model also demonstrated that neither hUCMSCs nor hAMSCs significantly enhanced the lung metastasis. The data from cytokine array showed that 11 inflammatory factors, 8 growth factors and 11 chemokines were remarkably secreted and changed. CONCLUSIONS: In view of the data from in vitro and in vivo studies, the exploitation of hUCMSCs in new therapeutic strategies should be safe compared to hAMSCs under malignant conditions. Moreover, this is the first report to systematically elucidate the possible molecular mechanisms involved in UCMSC- and AMSC-affected tumor growth and metastasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02859-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6482126
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64821262019-05-15 Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo Meng, Ming-Yao Li, Lin Wang, Wen-Ju Liu, Fei-Fei Song, Jian Yang, Song-Lin Tan, Jing Gao, Hui Zhao, Yi-Yi Tang, Wei-Wei Han, Rui Zhu, Kai Liao, Li-Wei Hou, Zong-Liu J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: Human mesenchymal stem cells (hMSCs) have been applied in a variety of therapies recently. However, the role of MSCs in tumor progression remains largely elusive. Some studies demonstrated that MSCs can promote tumor growth, while others had opposite results. Therefore, the lack of evidence about the effect of MSCs on tumor cells impedes its further use. METHODS: In the current study, hMSCs from amniotic membrane (hAMSCs) and umbilical cord (hUCMSCs) were used to evaluate the effects of MSCs on tumor development in vitro and in vivo. Two different animal models based on subcutaneous xenograft bearing nude mice and a murine experimental metastatic model were established for in vivo study. Moreover, cytokines regulated by MSCs co-cultured with cancer cells SPC-A-1 were also analyzed by cytokine array. RESULTS: Our results indicated that hUCMSCs not only did not promote proliferation in cancer cells, but also inhibited migration. In addition, they inhibited tube formation in human umbilical vein endothelial cells (HUVECs). Although hAMSCs also showed inhibitory effects on cancer cell motility, the proliferation of cancer cells was indeed enhanced. The in vivo data revealed that hUCMSCs did not promote tumor progression in lung adenocarcinoma and gastric carcinoma xenografts. Nevertheless, hAMSCs could do. The results from murine experimental metastatic model also demonstrated that neither hUCMSCs nor hAMSCs significantly enhanced the lung metastasis. The data from cytokine array showed that 11 inflammatory factors, 8 growth factors and 11 chemokines were remarkably secreted and changed. CONCLUSIONS: In view of the data from in vitro and in vivo studies, the exploitation of hUCMSCs in new therapeutic strategies should be safe compared to hAMSCs under malignant conditions. Moreover, this is the first report to systematically elucidate the possible molecular mechanisms involved in UCMSC- and AMSC-affected tumor growth and metastasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02859-6) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-02-25 2019 /pmc/articles/PMC6482126/ /pubmed/30805774 http://dx.doi.org/10.1007/s00432-019-02859-6 Text en © The Author(s) 2019 OpenAccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article – Cancer Research
Meng, Ming-Yao
Li, Lin
Wang, Wen-Ju
Liu, Fei-Fei
Song, Jian
Yang, Song-Lin
Tan, Jing
Gao, Hui
Zhao, Yi-Yi
Tang, Wei-Wei
Han, Rui
Zhu, Kai
Liao, Li-Wei
Hou, Zong-Liu
Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title_full Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title_fullStr Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title_full_unstemmed Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title_short Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
title_sort assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo
topic Original Article – Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482126/
https://www.ncbi.nlm.nih.gov/pubmed/30805774
http://dx.doi.org/10.1007/s00432-019-02859-6
work_keys_str_mv AT mengmingyao assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT lilin assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT wangwenju assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT liufeifei assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT songjian assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT yangsonglin assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT tanjing assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT gaohui assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT zhaoyiyi assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT tangweiwei assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT hanrui assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT zhukai assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT liaoliwei assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo
AT houzongliu assessmentoftumorpromotingeffectsofamnioticandumbilicalcordmesenchymalstemcellsinvitroandinvivo